Skip to main content
Top
Published in: Infection 3/2014

01-06-2014 | Correspondence

Emergence of Klebsiella pneumoniae liver abscesses in South-western Sydney

Authors: R. Chavada, J. Ng, M. Maley, J. Descallar

Published in: Infection | Issue 3/2014

Login to get access

Excerpt

Klebsiella pneumoniae liver abscess (KPLA) with metastatic infection has been recognised as an emerging infectious disease since being described originally from Taiwan (where it accounts for up to 78.5 % of all liver abscesses), subsequently from other Asian countries and, more recently, from non-Asian countries [1, 2]. The risk of metastatic infection with KPLA has been linked to APACHE II scores ≥20 and septic shock [1]. In non-Asian countries, KPLA syndrome cases have arisen predominantly in patients of Asian ethnicity [3, 4]. South-western Sydney is ethnically diverse, with 28 % of the total population and 12 % of regional hospital admissions being of Asian ethnicity (Australian Bureau of Statistics census data 2011; Clinical Information Department Statistics). We retrospectively reviewed patient files for this KPLA syndrome to determine their age, gender, ethnicity, travel history as recorded in formal infectious disease consultation, contact history, presenting features, APACHE II scores, diabetic status, baseline investigations, management and outcomes by the time of discharge. Data were analysed using SAS version 5.1 for Windows (Cary, NC, USA) and study approval was granted by the South Western Sydney Local Health District (SWSLHD) ethics committee (QA2010/015). …
Literature
1.
go back to reference Lee SS, Chen YS, Tsai HC, Wann SR, Lin HH, Huang CK, et al. Predictors of septic metastatic infection and mortality among patients with Klebsiella pneumoniae liver abscess. Clin Infect Dis. 2008;47:642–50.PubMedCrossRef Lee SS, Chen YS, Tsai HC, Wann SR, Lin HH, Huang CK, et al. Predictors of septic metastatic infection and mortality among patients with Klebsiella pneumoniae liver abscess. Clin Infect Dis. 2008;47:642–50.PubMedCrossRef
2.
go back to reference Siu LK, Yeh KM, Lin JC, Fung CP, Chang FY. Klebsiella pneumoniae liver abscess: a new invasive syndrome. Lancet Infect Dis. 2012;12:881–7.PubMedCrossRef Siu LK, Yeh KM, Lin JC, Fung CP, Chang FY. Klebsiella pneumoniae liver abscess: a new invasive syndrome. Lancet Infect Dis. 2012;12:881–7.PubMedCrossRef
3.
go back to reference Anstey JR, Fazio TN, Gordon DL, Hogg G, Jenney AW, Maiwald M, et al. Community-acquired Klebsiella pneumoniae liver abscesses—an “emerging disease” in Australia. Med J Aust. 2010;193:543–5.PubMed Anstey JR, Fazio TN, Gordon DL, Hogg G, Jenney AW, Maiwald M, et al. Community-acquired Klebsiella pneumoniae liver abscesses—an “emerging disease” in Australia. Med J Aust. 2010;193:543–5.PubMed
4.
go back to reference Pastagia M, Arumugam V. Klebsiella pneumoniae liver abscesses in a public hospital in Queens, New York. Travel Med Infect Dis. 2008;6:228–33.PubMedCrossRef Pastagia M, Arumugam V. Klebsiella pneumoniae liver abscesses in a public hospital in Queens, New York. Travel Med Infect Dis. 2008;6:228–33.PubMedCrossRef
5.
6.
go back to reference Barakate MS, Stephen MS, Waugh RC, Gallagher PJ, Solomon MJ, Storey DW, et al. Pyogenic liver abscess: a review of 10 years’ experience in management. Aust N Z J Surg. 1999;69:205–9.PubMedCrossRef Barakate MS, Stephen MS, Waugh RC, Gallagher PJ, Solomon MJ, Storey DW, et al. Pyogenic liver abscess: a review of 10 years’ experience in management. Aust N Z J Surg. 1999;69:205–9.PubMedCrossRef
7.
go back to reference Moore R, O’Shea D, Geoghegan T, Mallon PW, Sheehan G. Community-acquired Klebsiella pneumoniae liver abscess: an emerging infection in Ireland and Europe. Infection. 2013;41:681–6.PubMedCrossRef Moore R, O’Shea D, Geoghegan T, Mallon PW, Sheehan G. Community-acquired Klebsiella pneumoniae liver abscess: an emerging infection in Ireland and Europe. Infection. 2013;41:681–6.PubMedCrossRef
Metadata
Title
Emergence of Klebsiella pneumoniae liver abscesses in South-western Sydney
Authors
R. Chavada
J. Ng
M. Maley
J. Descallar
Publication date
01-06-2014
Publisher
Springer Berlin Heidelberg
Published in
Infection / Issue 3/2014
Print ISSN: 0300-8126
Electronic ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-014-0617-1

Other articles of this Issue 3/2014

Infection 3/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.